Ledger.Open graph →
SEC Form D · filed September 5, 2025

TNF Pharmaceuticals, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Joshua N. Silverman · NEW YORK, NYExec · DirectorBruce T. Bernstein · New York, NYDirectorChristopher Schreiber · New York, NYDirectorMitchell J. Glass · New York, NYExec · DirectorBill J. White · New York, NYDirectorJoshua N. Silverman · NEW YORK, NYExec · DirectorBruce T. Bernstein · New York, NYDirectorIan Rhodes · New York, NYExecStephen J. Friscia · New York, NYDirectorDar Patel · New York, NYExec · DirectorRecall Capital Management LLC · SAN BRUNO, CADirectorChristopher Schreiber · New York, NYDirectorIan Rhodes · New York, NYExecMitchell J. Glass · New York, NYExec · DirectorStephen J. Friscia · New York, NYDirectorBill J. White · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗